ACRV
Acrivon Therapeutics, Inc.
2.10$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -656.4% | – | – | – | -2,047.2% | – | – | – | – | – | – | – | |
| – | 7.9% | – | – | – | 35.7% | – | – | – | – | – | – | – | |
| – | 162.3% | – | – | – | 437.1% | – | – | – | – | – | – | – | |
| – | 221.1% | – | – | – | 249.4% | – | – | – | – | – | – | – | |
| – | 61.1% | – | – | – | 97.5% | – | – | – | – | – | – | – | |
| – | 1,090.0% | – | – | – | 1,699.5% | – | – | – | – | – | – | – | |
| – | -106.7% | – | – | – | -76.3% | – | – | – | – | – | – | – | |
| – | 326.8% | – | – | – | -423.9% | – | – | – | – | – | – | – | |
| – | -717.5% | – | – | – | -2,144.7% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.